Delivery Order SPE2DB22D1106-SPE2DB25FEZB5
- Not listed
- The Defense Logistics Agency awarded a $4,416.87 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025, with a completion date of July 21, 2025. This competitively awarded, non-set-aside contract represents a routine pharmaceutical delivery under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion master contract valued through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $4,753.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,013.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. The contract, which is classified as a child contract with an ultimate completion date of July 21, 2025, was competitively awarded with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $13,551.66 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 24, 2025. This firm fixed price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order...
- The Defense Logistics Agency awarded a $2,252.25 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract, designated as firm fixed price with no set-aside provisions, was competitively awarded and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a $3,648.80 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price contract, which is part of a larger Indefinite Delivery Contract vehicle, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The...
- The U.S. Defense Department's Medical Supply Chain awarded a $12,012 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 22, 2025, with completion scheduled for July 23, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999.999 billion vehicle extending through...
- The Defense Logistics Agency awarded a delivery order valued at $8,410.31 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 4.5 mg/0.5 ml pens. The contract represents a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and was competitively awarded with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens valued at $1,417.72 on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026. The product will be...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZB5Delivery Order
The Defense Logistics Agency awarded a $4,521.27 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare programs. Trulicity, a diabetes medication, represents one of many pharmaceutical products AmerisourceBergen supplies to federal health systems through its DLA contract portfolio. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare procurement, AmerisourceBergen has demonstrated capability to meet federal requirements through open competition, delivering an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to defense and civilian healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 7/22/25 |